Cargando…
Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping
With the recent approval of 3 new antibody drug conjugates (ADCs) for solid tumors, this class of drugs is gaining momentum for the targeted treatment of cancer. Despite significant investment, there are still fundamental issues that are incompletely understood. Three of the recently approved ADCs c...
Autores principales: | Khera, Eshita, Cilliers, Cornelius, Smith, Michael D., Ganno, Michelle L., Lai, Katharine C., Keating, Thomas A., Kopp, Anna, Nessler, Ian, Abu-Yousif, Adnan O., Thurber, Greg M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779838/ https://www.ncbi.nlm.nih.gov/pubmed/33385970 http://dx.doi.org/10.1016/j.neo.2020.12.001 |
Ejemplares similares
-
Rational Design of Azastatin as a Potential ADC Payload with Reduced Bystander Killing
por: Hartmann, Rafael W., et al.
Publicado: (2020) -
Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?
por: Nessler, Ian, et al.
Publicado: (2018) -
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio Imaging
por: Nessler, Ian, et al.
Publicado: (2020) -
Tracking Antibody Distribution with Near-Infrared
Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on
Plasma Clearance
por: Cilliers, Cornelius, et al.
Publicado: (2017) -
A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer
por: Mckertish, Candice Maria, et al.
Publicado: (2023)